PrimeraDx Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • M&A

PrimeraDx General Information

Description

Developer of multiplex-based assays intended for infectious disease detection. The company provides scalable target amplification routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids, and it also offers a multiplexed assay providing quantitative and simultaneous measurement of viruses, fungal panels for mycology testing, enabling academic research centers, reference laboratories and bio-pharmaceutical companies for simultaneous detection and quantification of disparate target types, such as mRNA, miRNA, SNPs and DNA.

Contact Information

Formerly Known As
Primera Biosystems
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 171 Forbes Boulevard
  • Suite 1000
  • Mansfield, MA 02048
  • United States
+1 (508)
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Vertical(s)
Corporate Office
  • 171 Forbes Boulevard
  • Suite 1000
  • Mansfield, MA 02048
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PrimeraDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Mar-2014 Completed Profitable
5. Grant 26-Sep-2012 Completed Profitable
4. Later Stage VC (Series C) 21-Sep-2009 Completed Profitable
3. Early Stage VC (Series B) 07-Jan-2008 Completed Profitable
2. Early Stage VC (Series A2) 21-Nov-2007 $2.5M $13.5M Completed Profitable
1. Early Stage VC (Series A) 11-Jul-2005 $11M $11M Completed Startup
To view PrimeraDx’s complete valuation and funding history, request access »

PrimeraDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B1
Series A1 11,090,986 $0.001000 5% $1 $0.31 0x $1 4.62%
Series A 3,257,214 $0.001000 5% $1 $0.31 0x $1 1.36%
To view PrimeraDx’s complete cap table history, request access »

PrimeraDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of multiplex-based assays intended for infectious disease detection. The company provides scalable target ampl
Discovery Tools (Healthcare)
Mansfield, MA
16 As of 2014

Berkeley, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PrimeraDx Competitors (6)

One of PrimeraDx’s 6 competitors is Onyx, a Venture Capital-Backed company based in Berkeley, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Onyx Venture Capital-Backed Berkeley, CA
Biocept Formerly VC-backed San Diego, CA
ACGT Corporation Wheeling, IL
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
Taconic Biosciences Private Equity-Backed Rensselaer, NY
To view PrimeraDx’s complete competitors history, request access »

PrimeraDx Patents

PrimeraDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003291144-A1 Sampling method and apparatus for amplification reaction analysis Inactive 21-Nov-2002
CA-2509769-A1 Sampling method and apparatus for amplification reaction analysis Inactive 21-Nov-2002
EP-1563097-A2 Sampling method and apparatus for amplification reaction analysis Inactive 21-Nov-2002
EP-1563097-A4 Sampling method and apparatus for amplification reaction analysis Inactive 21-Nov-2002
WO-2004048528-A2 Sampling method and apparatus for amplification reaction analysis Inactive 21-Nov-2002 B01L7/52
To view PrimeraDx’s complete patent history, request access »

PrimeraDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PrimeraDx Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Axiom Venture Partners Venture Capital Minority
Burrill & Co Merchant Banking Firm Minority
CHL Medical Partners Venture Capital Minority
InterWest Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

PrimeraDx FAQs

  • When was PrimeraDx founded?

    PrimeraDx was founded in 2004.

  • Where is PrimeraDx headquartered?

    PrimeraDx is headquartered in Mansfield, MA.

  • What is the size of PrimeraDx?

    PrimeraDx has 16 total employees.

  • What industry is PrimeraDx in?

    PrimeraDx’s primary industry is Discovery Tools (Healthcare).

  • Is PrimeraDx a private or public company?

    PrimeraDx is a Private company.

  • What is PrimeraDx’s current revenue?

    The current revenue for PrimeraDx is .

  • How much funding has PrimeraDx raised over time?

    PrimeraDx has raised $53.9M.

  • Who are PrimeraDx’s investors?

    Abingworth, Axiom Venture Partners, Burrill & Co, CHL Medical Partners, and InterWest Partners are 5 of 9 investors who have invested in PrimeraDx.

  • Who are PrimeraDx’s competitors?

    Onyx, Biocept, ACGT, Charles River Laboratories International, and Taconic Biosciences are some of the 6 competitors of PrimeraDx.

  • When was PrimeraDx acquired?

    PrimeraDx was acquired on 01-Mar-2014.

  • Who acquired PrimeraDx?

    PrimeraDx was acquired by Qiagen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process